Berikutnya

Putar otomatis

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Tampilan • 07/14/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis